相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells
Lina Yang et al.
CANCER LETTERS (2015)
Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer Chemotherapy
Kimitoshi Kohno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Deciphering the BRCA1 Tumor Suppressor Network
Qinqin Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression
Ya-Sai Yao et al.
ONCOLOGY REPORTS (2015)
Role of miR-155 in drug resistance of breast cancer
Dan-dan Yu et al.
TUMOR BIOLOGY (2015)
The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review
Yunshu Su et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer
Juan Li et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1
Xiao He et al.
TUMOR BIOLOGY (2015)
in vitro Modulation of P-glycoprotein, MRP-1 and BCRP Expression by Mangiferin in Doxorubicin-Treated MCF-7 Cells
Melva Louisa et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Copy Number Gain of hsa-miR-569 at 3q26.2 Leads to Loss of TP53INP1 and Aggressiveness of Epithelial Cancers
Pradeep Chaluvally-Raghavan et al.
CANCER CELL (2014)
Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
Shasha Tao et al.
CANCER RESEARCH (2014)
microRNA-200a Inhibits Cell Proliferation by Targeting Mitochondrial Transcription Factor A in Breast Cancer
Jia Yao et al.
DNA AND CELL BIOLOGY (2014)
DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity
Marijn T. M. van Jaarsveld et al.
MOLECULAR ONCOLOGY (2014)
miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer
Xiaohui Tan et al.
BREAST CANCER RESEARCH (2014)
microRNAs as Mediators of Drug Toxicity
Tsuyoshi Yokoi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2
Cindy Gallerne et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
External Qi of Yan Xin Qigong Inhibits Activation of Akt, Erk1/2 and NF-kappa B and Induces Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells
Xin Yan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Role of the Nrf2-ARE Pathway in Liver Diseases
Sang Mi Shin et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Concordant and Discordant Regulation of Target Genes by miR-31 and Its Isoforms
Yu-Tzu Chan et al.
PLOS ONE (2013)
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
J. Chuck Harrell et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients
Heidi Schwarzenbach et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer
Yoshifumi Nakayama et al.
ONCOLOGY REPORTS (2012)
Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma
Bo Peng et al.
PLOS ONE (2012)
Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1)
Bo Peng et al.
PROTEIN EXPRESSION AND PURIFICATION (2012)
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
Ding-Wu Shen et al.
PHARMACOLOGICAL REVIEWS (2012)
DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion
Francis Rodier et al.
JOURNAL OF CELL SCIENCE (2011)
Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
Matthias Port et al.
MOLECULAR CANCER (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
ATR mediates cisplatin resistance in a p53 genotype-specific manner
N. Sangster-Guity et al.
ONCOGENE (2011)
Molecular Stratification of Triple-Negative Breast Cancers
Charles M. Perou
ONCOLOGIST (2011)
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Smriti Kumar et al.
JOURNAL OF OVARIAN RESEARCH (2011)
MicroRNA-mediated drug resistance in breast cancer
Kristy R. Kutanzi et al.
CLINICAL EPIGENETICS (2011)
Cisplatin resistance: Preclinical findings and clinical implications
Beate Koeberle et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2010)
MicroRNA and drug resistance
J. Ma et al.
CANCER GENE THERAPY (2010)
A MicroRNA Targeting Dicer for Metastasis Control
Graziano Martello et al.
CELL (2010)
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
Igor P. Pogribny et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
Britta Stordal et al.
CURRENT CANCER DRUG TARGETS (2009)
MOLECULAR ORIGINS OF CANCER DNA Damage, Aging, and Cancer
Jan H. J. Hoeijmakers
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MECHANISMS OF CHEMOTHERAPEUTIC DRUG RESISTANCE IN CANCER THERAPY-A QUICK REVIEW
Fu-Shing Liu
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2009)
MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
Nuo Yang et al.
CANCER RESEARCH (2008)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth
Julia Schultz et al.
CELL RESEARCH (2008)
Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells
Sang Kyum Kim et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Anti proliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma
Yi Peng et al.
MOLECULAR CANCER RESEARCH (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling
N. M. Reddy et al.
ONCOGENE (2008)
Suppression of non-small cell lung tumor development by the let-7 microRNA family
Madhu S. Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition
Emily L. Paterson et al.
THESCIENTIFICWORLDJOURNAL (2008)
Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation
Christian Perotti et al.
BREAST CANCER RESEARCH (2008)
Switching from repression to activation: MicroRNAs can up-regulate translation
Shobha Vasudevan et al.
SCIENCE (2007)
Iet-7 regulates self renewal and tumorigenicity of breast cancer cells
Fengyan Yu et al.
CELL (2007)
Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA
Matthew E. Klein et al.
NATURE NEUROSCIENCE (2007)
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
Muller Fabbri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Differential cadherin expression: Potential markers for epithelial to mesenchymal transformation during tumor progression
Georgia Agiostratidou et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2007)
The let-7 MicroRNA represses cell proliferation pathways in human cells
Charles D. Johnson et al.
CANCER RESEARCH (2007)
Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo
Igor Koturbash et al.
CARCINOGENESIS (2007)
Multidrug resistance in cancer: Its mechanism and its modulation
Ernest K. J. Pauwels et al.
DRUG NEWS & PERSPECTIVES (2007)
The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
Yong Sun Lee et al.
GENES & DEVELOPMENT (2007)
Gene expression profiling of breast cancer cells in response to gemcitabine:: NF-κB pathway activation as a potential mechanism of resistance
Hector Hernandez-Vargas et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation
Christine Mayr et al.
SCIENCE (2007)
Extensive post-transcriptional regulation of microRNAs and its implications for cancer
J. Michael Thomson et al.
GENES & DEVELOPMENT (2006)
Biomarkers and multiple drug resistance in breast cancer
L. O'Driscoll et al.
CURRENT CANCER DRUG TARGETS (2006)
High mobility group A2 potentiates genotoxic stress in part through he modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation
LN Boo et al.
CANCER RESEARCH (2005)
RAS is regulated by the let-7 MicroRNA family
SM Johnson et al.
CELL (2005)
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
J Takamizawa et al.
CANCER RESEARCH (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
The nuclear RNase III Drosha initiates microRNA processing
Y Lee et al.
NATURE (2003)
Cisplatin biochemical mechanism of action:: From cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways
MA Fuertes et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Exogenous expression of p21WAF1/CIP1 exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells
LF Qin et al.
CANCER LETTERS (2001)
Role of the Cdc25A phosphatase in human breast cancer
MG Cangi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
